Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Noel

Showing results (631-640 of 787) with videos related to

Pageof 79
Sort By:
Journal of the American College of Cardiology|February 28, 2024
Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass GraftingLamia Harik, Robert H Habib, Arnaldo Dimagli, et al.
JACC. Cardiovascular Imaging|January 15, 2011
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosusMariko L Ishimori, Rebecca Martin, Daniel S Berman, et al.
American Heart Journal|June 24, 2010
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, Marian B Olson, Candace McClure, et al.
International Journal of Cardiology|February 16, 2013
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome EvaluationThomas Rutledge, Tanya S Kenkre, Vera Bittner, et al.
Journal of the American Heart Association|October 1, 2017
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart AssociationGlenn N Levine, Richard A Lange, C Noel Bairey-Merz, et al.
Briefings in Bioinformatics|January 7, 2026
A novel two-sample Mendelian randomization framework integrating common and rare variants: application to assess the effect of HDL-C on preeclampsia riskYu Zhang, Ming Li, David M Haas, et al.
American Heart Journal Plus : Cardiology Research and Practice|May 20, 2025
Refractory angina in women with ischemia and no obstructive coronary artery disease - A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studyJudy M Luu, Janet Wei, Chrisandra Shufelt, et al.
Physiological Genomics|November 5, 2015
Genetic loci associated with nonobstructive coronary artery disease in Caucasian womenLiming Weng, Kent D Taylor, Yii-Der Ida Chen, et al.
Psychosomatic Medicine|March 22, 2012
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation studyKerry S Whittaker, David S Krantz, Thomas Rutledge, et al.
Journal of Women'S Health (2002)|August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
Pageof 79

Showing results (631-640 of 787) with videos related to

Sort By:
Pageof 79
Journal of the American College of Cardiology|February 28, 2024
Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass GraftingLamia Harik, Robert H Habib, Arnaldo Dimagli, et al.
JACC. Cardiovascular Imaging|January 15, 2011
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosusMariko L Ishimori, Rebecca Martin, Daniel S Berman, et al.
American Heart Journal|June 24, 2010
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, Marian B Olson, Candace McClure, et al.
International Journal of Cardiology|February 16, 2013
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome EvaluationThomas Rutledge, Tanya S Kenkre, Vera Bittner, et al.
Journal of the American Heart Association|October 1, 2017
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart AssociationGlenn N Levine, Richard A Lange, C Noel Bairey-Merz, et al.
Briefings in Bioinformatics|January 7, 2026
A novel two-sample Mendelian randomization framework integrating common and rare variants: application to assess the effect of HDL-C on preeclampsia riskYu Zhang, Ming Li, David M Haas, et al.
American Heart Journal Plus : Cardiology Research and Practice|May 20, 2025
Refractory angina in women with ischemia and no obstructive coronary artery disease - A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studyJudy M Luu, Janet Wei, Chrisandra Shufelt, et al.
Physiological Genomics|November 5, 2015
Genetic loci associated with nonobstructive coronary artery disease in Caucasian womenLiming Weng, Kent D Taylor, Yii-Der Ida Chen, et al.
Psychosomatic Medicine|March 22, 2012
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation studyKerry S Whittaker, David S Krantz, Thomas Rutledge, et al.
Journal of Women'S Health (2002)|August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
Pageof 79